Stress signals link pre-existing sickness with susceptibility to bacterial infection
Repeated stress signals made in cells with metabolism-associated disease encourage the growth of invading bacteria
Mitochondrial diseases disrupt the power generating machinery within cells and increase a person's susceptibility to bacterial infection, particularly in the lungs or respiratory tract. A new study published in Disease Models & Mechanisms (DMM) shows that infection with the pneumonia causing bacteria Legionella, is facilitated by an increased amount of a signaling protein that is associated with mitochondrial disease.
Patients with mitochondrial disease exhibit a wide range of symptoms including diabetes, blindness, deafness, stroke-like episodes, epilepsy, ataxia, muscle weakness and kidney disease. The metabolic abnormalities that cause these effects also induce a stress signal intended to help the body overcome its energy deficit. The stress-signal induces the production of more mitochondria, the energy generating 'powerplants' of the body, in the hopes that more mitochondria will result in a better power supply. Researchers now show that the stress-signal associated with mitochondrial disease facilitates the growth and reproduction of the lung-infecting bacteria, Legionella.
Cells with mitochondrial disease increase their production of a signaling protein called AMP-activated protein kinase (AMPK), to promote the generation of more energy producing mitochondria. Infectious bacteria, like Legionella, target the mitochondria and might use them to supplement their own needs and survival requirements. By manipulating AMPK levels, scientists were able to directly influence the ability of bacteria to replicate inside of the single-celled organism, Dictyostelium.
Striking similarities that exist between simple organisms like Dictyostelium and humans allow scientists to use them to understand human disease. Dictyostelium is a free-living amoeba whose rapid movements make it useful to study motility and energy regulation, and in this case, the association between energy regulation and susceptibility to infection. Like humans, Dictyostelium can be infected by Legionella and quickly responds by producing a host of metabolism-associated proteins. Another similarity between humans and Dictyostelium is that both use AMPK as an internal sensor to coordinate energy synthesis with energy needs. However, unlike humans, researchers can infect Dictyostelium with germs like Legionella in a controlled environment and determine the influence of various parameters on the course of infection.
Original publication: Lisa Francione, Paige K. Smith, Sandra L. Accari, Paul B. Bokko, Paul Fisher, Salvatore Bozzaro, Phillip E Taylor, Peter L. Beech; "Legionella pneumophila multiplication is enhanced by chronic AMPK signalling in mitochondrially diseased cells"; Disease Models & Mechanisms (DMM) 2009.
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Common diarrhoea pathogen unknown to many people
3-D imaging inside living organism, using quantum dots at the Cornell University - useful for tracking cells and visualizing tissue deep within living animals

Epigenetics and neural cell death

Point-of-care diagnostics for multiple diseases, courtesy of photonics technology - New generation of diagnostic systems

Researchers discover an alternative to PEG - rPEG as a new type of Poly(ethylene glycol): random chains offer multiple advantages for medical application
MorphoSys Appoints Head of Clinical Development

New device quickly detects harmful bacteria in blood - Tiny device could help professionals diagnose and fight deadly infections
Aureus Pharma licenses AurSCOPE Knowledge Databases to Bayer CropScience

Nanoplastics can disrupt human liver, lung cells’ processes in lab experiments - What happens when people unknowingly eat, drink or inhale nearly invisible pieces of plastic?
